Nektar Therapeutics (NKTR)
58.78
+1.50
(+2.62%)
USD |
NASDAQ |
Dec 09, 16:00
58.78
0.00 (0.00%)
After-Hours: 17:39
Nektar Therapeutics Shareholders Equity (Quarterly): 85.09M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 23.79B |
| Amicus Therapeutics, Inc. | 230.42M |
| Regeneron Pharmaceuticals, Inc. | 30.96B |
| Rigel Pharmaceuticals, Inc. | 117.61M |
| Zevra Therapeutics, Inc. | 133.16M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 301.35M |
| Total Liabilities (Quarterly) | 216.26M |
| Debt to Equity Ratio | 1.964 |
| Current Ratio | 4.241 |
| Net Debt Paydown Yield | 1.07% |